The Asia-Pacific Journal of Ophthalmology

Asia-Pacific Journal of Ophthalmology:

Issue 6, November/December 2018 Review Article

Controlling Progression of Myopia: Optical and Pharmaceutical Strategies

Sankaridurg, Padmaja; Conrad, Fabian; Tran, Huy; Zhu, Jianfeng

Author Information

From the *Brien Holden Vision Institute, Sydney; †School of Optometry and Vision Science, University of New South Wales, Sydney, Australia; ‡Department of Clinical Research, Hai Yen Eye Care, Ho Chi Minh City, Vietnam; and §Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China.

Reprints: Padmaja Sankaridurg, Brien Holden Vision Institute, Level 4, Rupert Myers Building, UNSW, NSW 2052, Australia.


The burden associated with the rising prevalence of myopia and high myopia, and the associated vision impairment and sight-threatening complications, has triggered the need to evaluate strategies to control the progression of myopia. We provide an overview of the literature on the use of optical (spectacles, contact lenses, and orthokeratology) and pharmaceutical approaches to slow progress of myopia. The evidence indicates that myopia progression can be slowed by varying degrees using these strategies. All approaches play a role in the management of myopia as needs and requirements of an individual vary based on age, suitability, affordability, safety of the approach, subjective needs of the individual, and rate of progression. This review also identifies and discusses the lack of long-term efficacy data and rebound on discontinuation of myopia control products.

Full Text

View PDF Online

Download PDF

APJO Express

More About APAO

  • 1
  • 2
  • 3
  • 4
< >
All Rights Reserved © Asia-Pacific Academy of Ophthalmology